Gonorrhea Therapeutics Market News and Recent Developments: Innovations in Antibiotic Therapies and STI Management
The Gonorrhea Therapeutics Market is witnessing steady growth due to the increasing prevalence of sexually transmitted infections (STIs), growing awareness regarding early diagnosis and treatment, and continuous advancements in antimicrobial therapies. Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, remains one of the most common sexually transmitted infections worldwide. The disease affects millions of individuals annually and poses a significant public health challenge due to the emergence of antibiotic-resistant strains.
